Synapse - Hematologic Malignancies, Division of

Results (44)

Pathologic response and histologic features of cytoreductive nephrectomy (CN) following immunotherapy (IO) for patients with metastatic renal cell carcinoma (RCC)

Meeting Abstract

Wu, C. Y.; Reese, S.; Al-Ahmadie, H.; Fine, S.; Gopalan, A.; Sarungbam, J.; Sirintrapun, S. J.; Kotecha, R.; Voss, M.; Coleman, J.; more...
Laboratory Investigation (2023)

Fulltext@MSK | Save

Distinct genomic alterations in radiation-induced angiosarcoma compared to other radiation-associated sarcoma histologies: Rationale for individualized therapeutic targeting

Meeting Abstract

Dermawan, J.; Chi, P.; Tap, W.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K.; Antonescu, C.
Laboratory Investigation (2023)

Fulltext@MSK | Save

Applying lymphgen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large b-cell lymphoma (DLBCL)

Meeting Abstract

Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
Laboratory Investigation (2022)

Fulltext@MSK | Save

UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas

Meeting Abstract

Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Frequent TET2 mutations in histiocytic neoplasms

Meeting Abstract

Liu, Y.; Petrova-Drus, K.; Durham, B.; Baik, J.; Sigler, A.; Rampal, R.; Abdel-Wahab, O.; Diamond, E.; Dogan, A.; Yabe, M.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Single-cell evaluation of myelodysplastic syndrome stem cells identifies determinants of hypomethylating agent response and a novel prognostic gene signature

Meeting Abstract

Javidiparsijani, S.; Dolgalev, I.; Vijay, P.; Gonzalez, M. D.; Devlin, S.; Klimek, V.; Chung, S.; Mason, C.; Park, C.
Laboratory Investigation (2020)

Fulltext@MSK | Save

Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)

Meeting Abstract

Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases

Meeting Abstract

Liu, Y.; Mata, D.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M.; Zhang, Y.; Dogan, A.; Tallman, M.; Levine, R.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Frequent RUNX1 and TP53 mutations in secondary acute myeloid leukemia with mixed phenotype

Meeting Abstract

Galera, P.; Baik, J.; Famulare, C.; Sigler, A.; Zhang, Y.; Arcila, M.; Dogan, A.; Tallman, M.; Levine, R.; Glass, J.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

PICALM-MLLT10 fusion commonly presents with extramedullary acute leukemia and often with a mixed phenotype (MPAL)

Meeting Abstract

Tashkandi, H.; Xiao, W.; Roshal, M.; Zhang, Y.; Arcila, M.; Benayed, R.; Sen, F.; Ho, C.; Baik, J.; Pichardo, J.; more...
Laboratory Investigation (2019)

Fulltext@MSK | Save